Neutrophil Activation and Adhesiveness in Coronary Artery Disease: Results From the COLCHICINE‐PCI Biomarker Substudy

Registration URL: https://clinicaltrials.gov. Unique identifier: NCT02594111.

Bibliographic Details
Published in:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Main Authors:	Nina Talmor, Michael H. Pillinger, Yuhe Xia, Ana Leonard, Fatmira Curovic, Binita Shah
Format:	Article
Language:	English
Published:	Wiley 2024-10-01
Subjects:	adhesiveness biomarkers colchicine coronary artery disease neutrophil activation percutaneous coronary intervention
Online Access:	https://www.ahajournals.org/doi/10.1161/JAHA.124.036701

Similar Items

Dual anti-platelet therapy with colchicine after PCI for acute coronary syndrome: A literature review
by: S. Yambolov, et al.
Published: (2024-09-01)

Clinical outcomes of patients undergoing percutaneous coronary intervention treated with colchicine
by: César E. Soria Jiménez, et al.
Published: (2023-05-01)

Efficacy and safety of mono antiplatelet therapy with colchicine in acute coronary syndrome patients following percutaneous coronary intervention: rationale and design of the MACT II trial
by: Ji Yong Jang, et al.
Published: (2025-10-01)

Inflammation and platelet reactivity during adjunctive colchicine versus aspirin in patients with acute coronary syndrome treated with potent P2Y12 inhibitor
by: Seung-Yul Lee, et al.
Published: (2024-04-01)

Formulation and Evaluation of a Drug-in-Adhesive Patch for Transdermal Delivery of Colchicine
by: Yaran Lei, et al.
Published: (2022-10-01)

Colchicine in the Management of Acute Coronary Syndrome: A Meta-analysis
by: Jason Nogic, et al.
Published: (2023-01-01)

Colchicine efficacy comparison at varying time points in the peri-operative period for coronary artery disease: a systematic review and meta-analysis of randomized controlled trials
by: Zhi-Yang Wei, et al.
Published: (2023-08-01)

Efficacy of Colchicine in Improving Outcomes in Coronary Artery Disease: A Systematic Review and Meta-Analysis
by: Nahush Bansal, et al.
Published: (2025-06-01)

Role of inflammation and evidence for the use of colchicine in patients with acute coronary syndrome
by: Juan Francisco Bulnes, et al.
Published: (2024-06-01)

Risk of coronary artery disease in patients with gout on treatment with Colchicine: A systematic review and meta-analysis
by: Muhammad U. Siddiqui, et al.
Published: (2023-04-01)

The Role of Colchicine in Atherosclerosis: From Bench to Bedside
by: Leticia González, et al.
Published: (2022-07-01)

Editorial: Role of colchicine in atherosclerosis
by: Ashish Misra, et al.
Published: (2024-11-01)

Changes in the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios before and after percutaneous coronary intervention and their impact on the prognosis of patients with acute coronary syndrome
by: Jianlong Sheng, et al.
Published: (2021-08-01)

Colchicine in Patients With Coronary Artery Disease: A Systematic Review and Meta‐Analysis of Randomized Trials
by: Thomas Kofler, et al.
Published: (2021-08-01)

Considering Initial “PCI Turndown” as a Risk Factor for Subsequent PCI
by: Tayyab Shah, et al.
Published: (2024-06-01)

Colchicine and diabetes in patients with chronic coronary artery disease: insights from the LoDoCo2 randomized controlled trial
by: Niekbachsh Mohammadnia, et al.
Published: (2023-10-01)

Association of Circulating Neutrophils with Relative Volume of Lipid-Rich Necrotic Core of Coronary Plaques in Stable Patients: A Substudy of SMARTool European Project
by: Silverio Sbrana, et al.
Published: (2023-02-01)

Association between the variability of non-high-density lipoprotein cholesterol and the neutrophil-to-lymphocyte ratio in patients with coronary heart disease
by: Yifan Chen, et al.
Published: (2023-11-01)

Efficacy and safety of colchicine in patients with acute coronary syndrome: a systematic review and meta-analysis of randomized controlled trials
by: Parisa Fallahtafti, et al.
Published: (2025-09-01)

Colchicine and coronary heart disease risks: A meta-analysis of randomized controlled clinical trials
by: Zijun Ma, et al.
Published: (2022-09-01)

Colchicine therapy in cardiovascular medicine: A literature review
by: Jennifer Trube, et al.
Published: (2025-04-01)

A Meta-Analysis Evaluating the Colchicine Therapy in Patients With Coronary Artery Disease
by: Stefan Grajek, et al.
Published: (2021-12-01)

Cardiovascular Benefit of Colchicine in Relation to Baseline Risk: A Secondary Analysis of the LoDoCo2 Trial
by: Niekbachsh Mohammadnia, et al.
Published: (2025-05-01)

High absolute neutrophil count with type 2 diabetes is associated with adverse outcome in patients with coronary artery disease: A large-scale cohort study
by: Jining He, et al.
Published: (2023-04-01)

Study on the mechanism of action of colchicine in the treatment of coronary artery disease based on network pharmacology and molecular docking technology
by: Yunfeng Yu, et al.
Published: (2023-06-01)

Recent Evidence on Advances in PCI Treatment for Left Main Coronary Artery Disease
by: Xian Jin, et al.
Published: (2022-10-01)

Combined prediction value of coronary plaque burden, serum creatinine, MLR and NLR in reinfarction risk after PCI in middle-aged and elderly patients with myocardial infarction
by: Huanhua Du, et al.
Published: (2025-06-01)

Dynamic coronary roadmap-guided PCI reduces contrast volume and radiation time compared to standard angiography PCI: A meta-analysis
by: Mohammad Al Hayek, et al.
Published: (2025-01-01)

Colchicine ameliorates myocardial injury induced by coronary microembolization through suppressing pyroptosis via the AMPK/SIRT1/NLRP3 signaling pathway
by: Hongqing Li, et al.
Published: (2024-01-01)

Hemolytic anemia after percutaneous coronary intervention (PCI): A case report
by: Yu Zhang, et al.
Published: (2024-11-01)

Bifurcation lesions in the context of a PCI CTO - insight from Belgrade single center CTO registry
by: Juričić Stefan, et al.
Published: (2023-01-01)

The Impact of Sickle Cell Disease on Acute Coronary Syndrome and PCI Outcomes
by: Abdulmajeed Alharbi, et al.
Published: (2023-12-01)

Colchicine in Cardiac Surgery: The COCS Randomized Clinical Trial
by: Vladimir Shvartz, et al.
Published: (2022-10-01)

Comparison of the preventive effect of colchicine versus diphenhydramine, prednisolone, and a combination therapy on intraperitoneal adhesion bands: an experimental study in rats
by: Seyed Ali Malekhosseini, et al.
Published: (2023-04-01)

Targeting Inflammation with Galectin-3 and PIIINP Modulation Among ST-Segment Elevation Acute Coronary Syndrome Patients Underwent Delayed Percutaneous Coronary Intervention
by: Saskia Dyah Handari, et al.
Published: (2025-01-01)

Outcomes of chronic total occlusion (CTO) percutaneous coronary intervention (PCI) according to race: Insights from the PROGRESS-CTO registry
by: Evangelia Vemmou, et al.
Published: (2022-03-01)

What is the lowest lethal dose of colchicine?
by: Vanyo Mitev
Published: (2023-03-01)

Monitoring and Assessing Cardiac Patients’ Knowledge and Adherence Pre-Discharge Post-PCI
by: Fayez Al-Zubair, et al.
Published: (2025-01-01)

Neutrophil activation and neutrophil derived neutrophil extracellular trap formation in patients with coronary artery ectasia
by: Yuchao Guo, et al.
Published: (2020-03-01)

Combination of D-dimer level and neutrophil to lymphocyte ratio predicts long-term clinical outcomes in acute coronary syndrome after percutaneous coronary intervention
by: Ling-Feng Gu, et al.
Published: (2023-08-01)